Don Dion is the publisher of the Fidelity Independent Adviser (http://www.fidelityadviser.com/) family of newsletters, which provides to a broad range of investors Don’s commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than... More
As many of us were recovering from the flu, AstraZeneca reported strong earnings growth in the third quarter. The company's nasal spray vaccine is in great demand as many people like me avoid needles. Investors looking for diversified exposure to the major companies that are selling high demand drugs to battle the flu should consider the IShares Global Health Care ETF (IXJ). This ETF’s top holdings include Novartis (7%), GlaxoSmithKline (5.5%) and AstraZeneca (3.4%). This ETF has moved up recently in my ETF Action ratings. For more on which ETFs have strong momentum check out the ETF Action tab at the top of the page.
To access my special Market Outlook for 2010 report, click here
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha
community. Instablog posts are not selected, edited or screened by Seeking Alpha editors,
in contrast to contributors' articles.
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
ETF for the FLU 0 comments
To access my special Market Outlook for 2010 report, click here
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Latest Followers
Posts by Ticker
Latest Comments
Most Commented
Posts by Themes